Literature DB >> 18563312

The schizophrenia and Toxoplasma gondii connection: infectious, immune or both?

Gulden Sonmez Tamer1, Devrim Dundar, Irem Yalug, Seyda Caliskan, Suleyman Yazar, Ahmet Aker.   

Abstract

INTRODUCTION: Recent research has suggested a possible link between toxoplasmic agents and schizophrenia. We aimed to assess this by measuring Toxoplasma gondii-associated antibodies in schizophrenia patients and controls
METHODS: We used a commercially available enzyme-linked immunosorbent assay (ELISA) kit to measure the level of immunoglobulin G (IgG) and IgM antibodies in serum samples from schizophrenia patients (n=40) and from a group of non-schizophrenic control subjects (n=37)
RESULTS: Among schizophrenic patients, 16 (40%) showed IgG seropositivity and two (5%) showed IgM seropositivity. Among the control group, five (13.5%) were found have IgG seropositivity and one (2.7%) showed IgM seropositivity. In our study we found that IgG T gondii antibodies were significantly higher in schizophrenia patients compared with controls
CONCLUSIONS: This study supports the theory that toxoplasmic agents may have a role in the aetiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563312     DOI: 10.1007/s12325-008-0063-5

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  7 in total

1.  Toxoplasma gondii and other risk factors for schizophrenia: an update.

Authors:  E Fuller Torrey; John J Bartko; Robert H Yolken
Journal:  Schizophr Bull       Date:  2012-03-23       Impact factor: 9.306

2.  Meta-Analysis of Anti-Toxoplasma gondii IgM Antibodies in Acute Psychosis.

Authors:  Joel M Monroe; Peter F Buckley; Brian J Miller
Journal:  Schizophr Bull       Date:  2014-11-09       Impact factor: 9.306

Review 3.  Toxoplasmosis and neuropsychiatric diseases: can serological studies establish a clear relationship?

Authors:  Silvia Fabiani; Barbara Pinto; Fabrizio Bruschi
Journal:  Neurol Sci       Date:  2012-09-26       Impact factor: 3.307

4.  Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study.

Authors:  José Gutiérrez-Fernández; Juan de Dios Luna Del Castillo; Sara Mañanes-González; José Antonio Carrillo-Ávila; Blanca Gutiérrez; Jorge A Cervilla; Antonio Sorlózano-Puerto
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-27       Impact factor: 2.570

5.  Seropositivity and serointensity of Toxoplasma gondii antibodies and DNA among patients with schizophrenia.

Authors:  Ainsah Omar; Osman Che Bakar; Nor Fatini Adam; Hakim Osman; Arina Osman; Ahmad Hatim Suleiman; Mohd Rizal Abdul Manaf; Mohd Ikhsan Selamat
Journal:  Korean J Parasitol       Date:  2015-02-27       Impact factor: 1.341

6.  Associations of mental disorders and neurotropic parasitic diseases: a meta-analysis in developing and emerging countries.

Authors:  Labanté Outcha Daré; Pierre-Emile Bruand; Daniel Gérard; Benoît Marin; Valerie Lameyre; Farid Boumédiène; Pierre-Marie Preux
Journal:  BMC Public Health       Date:  2019-12-05       Impact factor: 3.295

7.  Seroepidemiological Study of Toxoplasma gondii Infection among Psychiatric Patients in Mashhad, Northeast of Iran.

Authors:  Ebrahim Abdollahian; Reza Shafiei; Naghmeh Mokhber; Kurosh Kalantar; Abdolmajid Fata
Journal:  Iran J Parasitol       Date:  2017 Jan-Mar       Impact factor: 1.012

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.